logo

Benitec Biopharma (BNTC)



Trade BNTC now with
  Date
  Headline
2/14/2022 8:04:25 AM Benitec Biopharma Q2 Loss/shr Narrows To $0.59 From $0.76 Prior Year
11/15/2021 8:14:04 AM Benitec Biopharma Q1 Loss/shr $0.62 Vs. Loss/shr $2.45 Prior Year
9/20/2021 8:08:48 AM Benitec Biopharma FY Loss Attributable To Shareholders $13.9 Mln Or $3.23/shr Vs Loss Of $8.3 Mln Or $8.10/Shr Last Year
9/8/2021 8:17:44 AM Benitec Biopharma Provides Positive Updates On BB-301 Pilot Dosing Study In Large Animals
9/8/2021 8:17:25 AM Benitec Biopharma Provides Positive Updates For BB-301 Development Program; BB-301 Phase 1b/2a Trial To Begin In 2022
4/27/2021 10:31:03 PM Benitec Biopharma Increases Bought Deal Offering Of Common Stock To $12.9 Mln
2/24/2021 8:31:50 AM Benitec Biopharma Announces Successful Results From Interim Analysis Of BB-301 Pilot Dosing Study